John Dawson
Directeur/Bestuurslid bij ERGOMED
Vermogen: 704 732 $ op 30-04-2024
Actieve functies van John Dawson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ERGOMED | Directeur/Bestuurslid | 09-03-2022 | - |
Independent Dir/Board Member | 09-03-2022 | - | |
Oxford Biomedica (UK) Ltd.
Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxford Biomedica (UK) Ltd. is a viral vector contract development and manufacturing organization (CDMO) based in Oxford, UK. Oxford Biomedica (UK has over 25 years of experience in the industry and is committed to enabling its clients to deliver life-changing therapies to patients worldwide. The British company offers innovative solutions to cell and gene therapy biotechnology and biopharma companies by working across key viral vector delivery systems including adeno-associated virus (AAV) and lentiviral delivery system. | Directeur/Bestuurslid | - | - |
Virocell Biologics Ltd.
Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Voorzitter | - | - |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer. | Directeur/Bestuurslid | - | - |
Loopbaan van John Dawson
Eerdere bekende functies van John Dawson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OXFORD BIOMEDICA PLC | Directeur/Bestuurslid | 01-08-2008 | 27-05-2022 |
Algemeen Directeur | 01-10-2008 | 28-01-2022 | |
PAION AG | Directeur/Bestuurslid | 21-05-2014 | 22-05-2019 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Directeur/Bestuurslid | - | - |
Financieel Directeur/CFO | 01-01-1996 | 01-01-2007 | |
Serono Laboratories (UK) Ltd. | Hoofd Administratief Officier | 01-01-1991 | 01-01-1996 |
Financieel Directeur/CFO | 01-01-1991 | 01-01-1996 |
Statistieken
Internationaal
Verenigd Koninkrijk | 6 |
Verenigde Staten | 2 |
Duitsland | 2 |
Operationeel
Director/Board Member | 6 |
Director of Finance/CFO | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 6 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
PAION AG | Health Technology |
OXFORD BIOMEDICA PLC | Health Technology |
ERGOMED | Commercial Services |
Bedrijven in privébezit | 5 |
---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Oxford Biomedica (UK) Ltd.
Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxford Biomedica (UK) Ltd. is a viral vector contract development and manufacturing organization (CDMO) based in Oxford, UK. Oxford Biomedica (UK has over 25 years of experience in the industry and is committed to enabling its clients to deliver life-changing therapies to patients worldwide. The British company offers innovative solutions to cell and gene therapy biotechnology and biopharma companies by working across key viral vector delivery systems including adeno-associated virus (AAV) and lentiviral delivery system. | Health Technology |
Virocell Biologics Ltd.
Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Health Technology |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer. | Commercial Services |
Serono Laboratories (UK) Ltd. |
- Beurs
- Insiders
- John Dawson
- Ervaring